Sanne S Veidal

Title: Sanne S Veidal: Innovator in Fibrosis Biomarker Assays

Introduction

Sanne S Veidal is a prominent inventor based in Olstykke, Denmark. She has made significant contributions to the field of biomedical research, particularly in the development of assays for diagnosing fibrosis. With a total of four patents to her name, her work is paving the way for advancements in medical diagnostics.

Latest Patents

Among her latest patents is a method of bioassay for the quantification of biomarkers useful in the diagnosis of fibrosis disease and prognosis of its development. This includes biomarkers indicative of the risk of developing fibrosis after a chronic injury. The invention focuses on degradation fragments of Collagen types I, III, IV, V, and VI, elastin, C-reactive protein, and proteoglycans such as Biglycan, Decorin, Versican, and Perlecan. Another significant patent involves methods of diagnosis or quantitation of fibrosis through an immunoassay that measures neo-epitope containing protein fragments in biofluid samples from patients. An elevation of these protein fragments is associated with the presence or extent of fibrosis.

Career Highlights

Sanne S Veidal is currently associated with Nordic Bioscience A/S, where she continues to innovate in the field of biomarker research. Her work has been instrumental in enhancing the understanding of fibrosis and its implications in chronic diseases.

Collaborations

She collaborates with notable colleagues such as Morten A Karsdal and Efstathios Vassiliadis, contributing to a dynamic research environment focused on advancing medical diagnostics.

Conclusion

Sanne S Veidal's contributions to the field of fibrosis biomarker assays highlight her role as a leading inventor in biomedical research. Her innovative methods are set to improve diagnostic capabilities and patient outcomes in the future.